The decrease in peripheral blood leukocyte and lymphocyte levels prevents patients with lymphoma from rapidly clearing the new coronavirus infection, similar to the general population, through CD4/CD8 and other mechanisms. This evidence concerns the gene CD4 and lymphoma.